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Objectives: To test the hypothesis that oral ciprofloxacin is equally effective as intravenous cefuroxime in preventing 
postoperative infectious complications in patients undergoing peripheral arterial surgery involving the groins. 
Design: Prospective, randomised, ouble-blind multicentre study. 
Materials: 580 patients undergoing arterial surgery involving the groins were randomised to ciprofloxacin (Ciproxin, 
Bayer) 750 mg x 2 p.o. or cefuroxime (Zinacef, Glaxo) 1.5 g x 3 i.v. given only on the day of surgery. The primary 
endpoint was wound~graft infection within 30 days postoperatively. Wound infection was defined as pus. 
Results: The wound infection rate in the ciprofloxacin group was 9.2% (27 patients) and in the cefuroxime group 9.1% 
(26 patients) according to intention to treat. For correct reatment the corresponding numbers were 9.5% (23 patients) and 
9.7% (22 patients), respectively. There were three graft infections (0.5%). The infection rate was 7.1% (31/433) in the 
absence and 14.9% (22/147) in the presence of distal ulcers (p < 0.05). S. allreus was the most common bacteria isolated. 
Forty percent of the wound infections were localised to the groins. By multivariate analysis presence of distal ulcer was the 
only factor of prognostic significance. 
Conclusions: The infection rate was similar in the two groups. Thus, oral administration of ciprofloxacin isan attractive, 
cost-effective and safe alternative to prophylaxis in vascular patients capable of taking oral medication on the day of 
surgery. 
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Introduction 
Antibiotic prophylaxis in vascular surgery is a well 
established routine. When synthetic vascular grafts 
are used prophylaxis is considered mandatory while 
the situation is less clear in patients with autologous 
grafts. 1 Several comparative studies have reported a 
significant reduction in wound infection rates (15-70% 
to 3-7%) following antibiotic prophylaxis compared to 
no prophylaxis. 2-4 In the study by Salzman 2the graft 
infection rate was reduced from 2.4 to 0.8%. 
Staphylococcus aureus has been the pathogen most 
commonly isolated from infected wounds, 5-7 espe- 
cially in the early postoperative period. Staphylococcus 
epidermidis is the commonest coagulase-negative bac- 
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teria isolated from vascular grafts. 8-1° These latter 
infections tend to appear long after graft implantation. 
The two types of staphylococci (aureus and epidermi- 
dis) together with Escherichia coli make up 75% of early 
and late wound/graft infections. 11 
The antibiotics most commonly used for prophy- 
laxis are penicillins, such as methicillin or fluclox- 
acillin, and cephalosporins such as cefazolin or cefur- 
oxime. Quinolones have not been subjected to 
randomised, large scale testing in vascular surgery. 
Ciprofloxacin is a 4-quinolone with a broad spectrum 
of activity. Commonly isolated microorganisms from 
postoperative infectious complications in vascular 
patients; Gram-positive pathogens such as S. aureus or 
S. epidermidis and Pseudomonas aeruginosa, are suscepti- 
ble to Ciprofloxacin even though the drug is more 
effective against gram-negative bacteria. The intra- 
venous route for prophylactic antibiotics is the usual 
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practice in most vascular institutions. This route of 
administration is associated with significant cost due 
to use of nursing time. It was felt that an oral regime 
would be more cost-effective provided its efficacy and 
safety could be demonstrated especially as the com- 
monest operations are performed for extra-abdominal 
arterial disease. 
This study compared two antibiotic prophylaxis 
regimes in vascular patients. The aim was to test the 
hypothesis that oral administration of ciprofloxacin 
was equally effective as intravenous cefuroxime when 
given on the day of surgery to patients undergoing 
peripheral vascular reconstructions involving the 
groins. 
intravenously. The first dose was given at time of 
premedication (1-2 h preoperatively) and the drugs 
were only given during the first 24 h postoperatively. 
The second dose of ciprofloxacin was given 12 h after 
the first. Cefuroxime was given at 8 h intervals. The 
study was double blind with appropriate placebo pills 
or infusions. Wound infection was defined as pus from 
a surgical wound, with or without a positive bacterial 
culture. Graft infection was defined as persistent 
wound infection communicating with the graft. 
Patients who did not receive at least 80% of the 
prophylactic dose were excluded as were patients 
given antibiotics during the follow up without any 
proven infection or premature termination for other 
reasons (e.g. unwillingness to cooperate, death). 
Material and Methods Statistics 
Five hundred and eighty patients were randomised 
into a multicentre double-blind prospective trial. The 
units for peripheral vascular surgery at the county 
hospitals in Borfis, Halmstad, Trollh~ttan (NAL) and 
Varberg and the University hospitals Ostra and 
Sahlgrenska, G6teborg, Sweden participated in the 
study. The hospitals are situated in western Sweden 
within a radius of 150 km. 
Patients cheduled for arterial reconstruction of the 
legs involving an inguinal incision were randomised 
into the trial. The patients had to be able to take their 
oral medication on the evening after surgery. Patients 
were excluded from the study if their general condi- 
tion contraindicated surgery, if they had known 
allergy to quinolones or if they had taken any 
antibiotics within 48 h of randomisation. Patients were 
stratified according to the presence or absence of distal 
ulcers. The primary endpoint was wound/graft infec- 
tion within 30 days postoperatively. Secondary end- 
point was the prevention of infection at other sites 
(e.g. lungs, urinary tract). The patients were checked 
for infection or other complications at least on three 
occasions during the first postoperative month: 3-5, 
7-10 and 26-34 days postoperatively. Extra check-ups 
were performed if indicated. 
The recommended preoperative scrubbing regime 
was three preoperative showers with chlorhexidine 
(Hibiscrub R) within 24 h preoperatively. Shaving (if 
performed) was done immediately before surgery. 
Anesthesia was performed according to the preference 
of the anesthesiologist. Epidural anesthesia was rec- 
ommended. Thrombosis prophylaxis was used 
according to the local regime at the hospital. The study 
drugs were Ciprofloxacin (Ciproxin, Bayer) 750 mg× 
2 orally or Cefuroxime (Zinacef, Glaxo) 1.5 g × 3 
The sample size was calculated so that a probability of 
more than 80% would be achieved in assessing a 
difference of less than 6% units in infection probabili- 
ties according to a 95% C.I. provided that no difference 
existed. 
Fisher's permutation test 12'~3 which includes Fish- 
er's exact test as a special case, was used for 
comparison between treatment groups and between 
infected and non-infected patients. Fisher's test for 
paired data 12 was applied to compare laboratory 
variables before and after surgical treatment. To 
eliminate the influence of preoperative differences the 
Mantel test ~4 was used for comparison of the two 
treatment groups. The risk for infection was studied in 
a multivariate analysis using logistic regression. The 
prognostic variables and their importance was deter- 
mined by logistic model. 95% C.I.'s for proportions 
were determined exactly by use of the binomial 
distribution, for differences between proportions by 
use of a normal distribution approximation and for 
odds ratios by use of the SPSS procedure (SPSS for 
Windows: Base system user's guide, Release 6.0, 
Chicago 1993). Two-sided tests were used and the 
significance level was chosen as 0.05. Data are pre- 
sented as means +/-S.D. Analysis was performed on 
an intention to treat and to correct prophylaxis (after 
exclusion of drop-outs). The study was approved by 
the Ethics Committee at Gothenburg University and 
all patients gave their informed consent before trial 
entry. 
Results 
Five hundred and eighty patients were randomised to 
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the trial. The demographic composition of the groups 
did not differ (Table 1). Four hundred and sixty-eight 
patients remained after exclusions of drop-outs. Drop- 
outs (112 = 19.3%) were mainly due to antibiotics being 
given postoperatively without proven infection (66%). 
One month mortality was 2.8% (16/580). Surgery was 
performed for claudication in 223 (38%) and for 
critical ischaemia in 301 (52%) patients. Ten percent 
had surgery for other causes e.g. aneurysms. One 
hundred and forty-seven femoropopliteal bypasses 
above (25%) and 204 below knee (35%) and 68 
femorodistal (12%) reconstructions were performed. 
Other procedures (e.g. femorofemoral bypass) were 
performed in 176 patients (30%). Ninety-six percent of 
the patients had elective surgery while 26/573 (4%) 
were acute (within 5 days after onset of symptoms). 
Three hundred and eleven (53%) patients received 
synthetic grafts (Table 2). One hundred and forty- 
seven patients had distal ulcers. The first oral dose of 
prophylaxis was given 143 +/-54 rain and that of 
infusion 141 +/-54 min before start of surgery. 
The wound infection rate was 9.2% (27/293) in the 
ciprofloxacin group and 9.1% (26/287) in the cefurox- 
ime group according to intention to treat (N.s.). 
Analysis for correct prophylaxis gave corresponding 
values of 9.5% (23/241) and 9.7% (22/227), respec- 
tively (NS) (Table 3). There were three (0.5%) graft 
infections, according to intention to treat. Forty per- 
cent of the wound infections were localised to the 
groin, 20% to the thigh, 31% to the knee and 13% to the 
distal incisions. The perioperative hospital stay in 
non-infected patients was 8.1 +/-6.6 days compared 
to 10.7 +/-8.9 days in infected patients (NS). However, 
several patients with infections were readmitted on 
one or more occasions. Seventy-five percent of wound 
infections (40/53) were diagnosed after the second 
checkup at 7-10 days postoperatively. S. aureus was 
the most common bacteria isolated (60%, 62/102 
patients with positive culture) followed by S. epidermi- 
dis (10%, 10/102. The rate of infection at other sites 
(secondary end-point) were similar in both groups - 
ciprofloxacin 26/293, 8.9% and cefuroxime 22/287, 
7.7% (NS). The 30-day occlusion rate was 8% (45/580), 
and 9% (52/580) were reoperated within 30 days. The 
30-day infection rate in drop-out patients given 
antibiotics (without proven infection) was 7.1% 
(8/112). 
The infection rate was 7.1% (31/433) in the absence 
and 14.9% (22/147) in the presence of distal ulcers on 
the operated limb (p<0.05). Three patients with 
wound infection (presence of pus) had a negative 
bacterial culture. There were no differences in infec- 
tion rate between the two prophylactic regimes in 
patients with critical ischaemia or distal ulcer. There 
Table 1. Demographic details of the patient groups randomised to 
either ciprofloxacin 750 mg x 2 p.o. or cefuroxime 1.5 g x 3 i.v. as 
prophylaxis against prostoperative infection 
Ciprofloxacin Cefuroxime 
Number of patients 293 287 
Age (years) 72.5 71.5 
Diabetes 84 (28.6%) 68 (23.6%) 
Hypertension 195 (66.5%) 180 (62.7%) 
Distal ulcer 87 (29.6%) 84 (29.2%) 
Claudication 111 (37.8%) 112 (39%) 
Critical ischaemia 158 (54%) 143 (50%) 
Table 2. Types of operations performed in the two groups 
Ciprofloxacin Cefuroxime 
Femoropopliteal (AK) 66 81 
Femorapopliteal (BK) 106 98 
Femorodistal 35 33 
Femorofemoral 26 25 
Other 67 58 
Synthetic grafts 155 156 
Mean operation time (+/- S.D.) (rain) 142 (68) 143 (68) 
Table 3. Wound infection rate within 30 days postoperatively in 
the two groups 
Ciprofloxacin Cefuroxime 
Intention to treat 27/260 (9.2%) 26/247 (9.1%) 
Correct treatment 23/218 (9.5%) 22/202 (9.7%) 
Presence ofdistal ischaemic ulcer 10/73 (13.6%) 12/74 (16.2%) 
was no correlation between infection and duration of 
the operation. Patients with claudication had a sig- 
nificantly lower risk of postoperative wound infection 
(p < 0.029) than patients with critical ischaemia, ulcer 
or previous antibiotic therapy (within 3 months) 
(p < 0.015, 0.004 and 0.01, respectively). The presence 
of distal ulcers preoperatively increased the risk of 
postoperative infection by a factor of 2.9 compared to 
claudication and 1.2 compared to critical ischaemia. 
The wound infection rate was 8.1% when synthetic 
grafts were used as compared to 12.3% for veins (NS). 
A logistic regression analysis was performed by a 
forward procedure with postoperative wound infec- 
tion as dependent variable and 18 variables (eg. age, 
BMI, sex, chronic disease, acute disease, critical ischae- 
mia, rest pain and others) as independent ones. The 
last step of the procedure included one variable only, 
distal ulcer, ~ = 0.90, (p = 0.0023) and constant = -2.61. 
Thus, in the multivariate analysis presence of distal 
ulcer was the only significant prognostic factor. 
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Routine laboratory variables did not differ between 
the two prophylaxis groups. 
Discussion 
Definition of infection 
The most important issue when comparing studies on 
use of prophylactic antibiotics is the definition of 
infection. Szilagyi et al. ~5 defined three groups of 
wound infections. Group I was superficial involve- 
ment of skin or subcutaneous tissue. Group II 
involved deep subcutaneous ti sue possibly requiring 
debridement. Group III involved the graft. With 
exception from the third group these definitions are 
based on subjective judgement. In the study by 
Edwards et al. 7 group I patients were excluded since 
they were considered to be minor events without 
certain relation to intraoperative events. In a study by 
Holm 16 the presence of pus was used for character- 
ising one type of infection. Other defined groups 
included consequences such as prolonged hospital 
stay or need for surgical revision. Depending on the 
definition the wound infection rate varied between 1
and 12%. The highest frequency was found in the 
group corresponding to group I according to Szilagyi 
et aI. 15 
In the present study the intention was to minimise 
subjective valuations. Hence, the presence of pus was 
used to define infection. Bacterial culture was advo- 
cated but even when negative, infection was con- 
sidered to be present if pus was positively docu- 
mented. Three patients had pus with negative culture. 
A second group of patients without pus but with 
wound problems uch as redness or dehiscence was 
recognised. Bacterial culture was taken from these 
wounds. This group corresponded to the group I 
according to Szilagyi et al. 15 and consisted of 18 
patients. There was no difference in this parameter 
between the two prophylactic regimes. Despite pos- 
itive culture in these 18 patients, infection was not 
considered to be present according to the definition. 
Several of these patients were given antibiotics. The 
majority of the patients in this category were seen by 
a general practitioner (GP). In the beginning of the 
study several patients had antibiotics prescribed by 
GPs due to suspected (but not proven) infection. As 
the study went on the GPs were asked to contact he 
vascular centre and refer these patients for an immedi- 
ate check-up by the surgical team or study nurse. 
Because of the inclusion criteria requiring oral 
medication, the majority of patients recruited under- 
went femoropopliteal or more distal reconstructions. 
The dominant location of wound infection was the 
groin, confirming previous tudies. 3'5-7"17-1s Failure to 
disinfect his region preoperatively may be one impor- 
tant reason. Josephs et al. 19 documented that the 
presence of positive bacterial culture in the inguinal 
lymph nodes had no bearing to occurrence of post- 
operative infection in vascular patients. Factors like 
diabetes or the existence of ulcers on the operated leg 
seem to be of more importance. Unsatisfactory surgi- 
cal technique may be one crucial factor. ~8 Tissue 
trauma, local ischaemia or haematoma may predis- 
pose to infection. The high incidence of infection in the 
distal wounds (knee and calf regions, 44%) was most 
probably related to the presence ischaemia. Herbst et 
al. 2° found no correlation between pre/peroperative 
bacterial cultures and postoperative positive cultures. 
Peroperatively identified S. epidermidis did not predis- 
pose for postoperative wound- or graft infection. In a 
study by Edwards et al. 7 no infections occurred in 
patients having abdominal or popliteal incisions. Most 
infections occurred in the groin. Of these patients, 29% 
with operation time over 230 rain developed infection. 
No patients with shorter operation time developed 
infection. In the present study the duration of the 
surgical procedure did not correlate with infection. 
However, since 419 patients (72%) had femoropopli- 
teal or femorodistal bypass the types of procedures 
were not comparable to the Edwards study. The 
infection rate in patients with claudication was 6.4% as 
compared to 13% for critical ischaemia (p < 0.05). 
Preoperative scrubbing with chlorhexidine was 
advocated in the present study. All patients but two 
adhered to the protocol. Between one and three 
preoperative showers were taken within 24 h of 
operation by 98% of the patients. Holm 16 described a
significant reduction of skin bacterial flora by preoper- 
ative disinfection with chlorhexidine showers. In that 
prospective study of 341 patients, half had a standard 
preoperative shower while the other half had intensi- 
fied preoperative chlorhexidine disinfection similar to 
the regime used in the present study. No systemic 
antibiotic prophylaxis was used. The infection rate in 
the routine group was 17.5% compared to 8% in the 
chlorhexidine group. However, recent study has failed 
to prove the efficacy of preoperative whole-body 
chlorhexidine disinfection in reducing wound infec- 
22 tion rate in general surgical patients. Preoperative 
shaving was performed in only 15% of the patients but 
in 84% of them it was done immediately before the 
start of surgery in order to minimise the risk for 
bacterial colonisation of epidermal lesions induced by 
the shaving. 
Several studies have tested antibiotic prophylaxis 
Eur J Vasc Endovasc Surg Vol 10, October 1995 
350 B. Risberg et al. 
with cephalosporins when given in a three-dose 
regime. 3'5'2° Others have explored single- or two-dose 
regime with apparently good results. 4'2x In the present 
study we used a three-dose regime of cefuroxime since 
it is a commonly used prophylaxis regime in many 
Swedish hospitals. A three-dose regime of cefuroxime 
is also the most commonly used form of prophylaxis 
according to a recent U.K. survey. 1 The postoperative 
infection rate has been reduced by prophylaxis in 
several studies on vascular patients. A recent study on 
559 patients demonstrated the efficacy of cefuroxime 
in reducing deep wound infections (infection rate 
2.6%). Another cephalosporin, cefazolin, was slightly 
better (1%) but the difference was not statistically 
significant. 7Ciprofloxacin is a 4-quinolone with broad 
spectrum of activity. The most commonly isolated 
bacteria in wounds of vascular surgical patients, S. 
aureus/epidermidis and P. aeruginosa, are all sensitive to 
the drug. s° The halflife for ciprofloxacin is 4 h. 
Following oral intake peak values of ciprofloxacin in 
serum are found after 1-2 h. Effective serum levels are 
maintained for over 12 h and tissue levels of 0.5 ug/  
mg are seen after 2 h of administration. The microbe 
most commonly isolated in the present study was S. 
aureus. The kinetics for ciprofloxacin indicated that 
effective levels (MIC values of > 0.25-1 rag/1 for S. 
aureus) were achieved for more than 12 h. z3 
The present study explored short term antibiotic 
prophylaxis against 30-day infection and only three 
graft infections were noticed (0.5%), although graft 
infections may appear after many months or years, x8'2° 
In the study by Lorenzen et aI. 18 53% of graft infections 
were diagnosed within 30 days postoperatively and it 
has been postulated that a reduction in early infection 
rates is important in preventing late graft infections. 
The concept that there is a difference in efficacy 
when an antibiotic drug is being used for prophylaxis 
as compared to therapy of an established infection, 
was confirmed in the present study. Ciprofloxacin, 
considered to be less effective for therapy against 
gram-positive bacteria (eg S. aureus) than Gram- 
negative bacteria, was found to be as effective as 
cefuroxime against postoperative infection when used 
for prophylaxis. The advantage of using oral prophy- 
laxis instead of intravenous injections or infusions is 
obvious from an economic point of view. The oral 
regime would cut the drug costs by 80%, notwith- 
standing savings in staff time as well as infusion 
equipment. 
In conclusion, this study demonstrated similar 
postoperative infection rates between prophylactic 
oral ciprofloxacin and intravenous cefuroxime. Cipro- 
floxacin is thus an attractive alternative for infection 
prophylaxis in vascular patients capable of taking oral 
medication on the day of surgery. 
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